
Kevin Niswender
Associate Program Director, Nutrition and Metabolic Disease Fellowship · Vanderbilt University Medical Center
Credentials: · · ·
History
- Present
Nutrition and Metabolic Disease Fellowship · Vanderbilt University Medical Center
Present
Research
Journal of Biological Chemistry · 1999 · 1,153 citations
International Journal of Obesity · 2013 · 598 citations
Intracellular signalling. Key enzyme in leptin-induced anorexia
Nature · 2001 · First of 6 authors · 484 citations

11 papers

10 papers

10 papers

8 papers · 8 as a fellow

8 papers

8 papers

8 papers

8 papers
Grants
- 1975–2031
Translational Research in Endocrinology And Diabetes (TREAD)
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $2.4M · Vanderbilt University Medical Center
- 2016–2022
GLP-1R Signaling in Allergic Inflammation
National Institute of Allergy and Infectious Diseases · R01
PI · $2.2M · Vanderbilt University Medical Center
- 1996–2022
Vanderbilt Diabetes Research Center
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $1.1M · Vanderbilt University Medical Center
- 2022
Vanderbilt Mouse Metabolic Phenotyping Center
National Institute of Diabetes and Digestive and Kidney Diseases · U2C
Project lead · $789.2K · Vanderbilt University
Clinical trials
- 2016–2022
Dietary Carbohydrate and GERD in Veterans
Principal investigator · Completed
VA Office of Research and Development
- 2012–2013
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
Principal investigator · Completed
Vanderbilt University
- 2011–2028
Insulin Detemir in Obesity Management
Principal investigator · Active not recruiting
Vanderbilt University
- 2020–2030



